Tepper, S. J., Vasudeva, R., Krege, J. H., Rathmann, S. S., Doty, E., Vargas, B. B., . . . Komori, M. (2020). Evaluation of 2‐Hour Post‐Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult‐to‐Treat Migraine Attacks. Headache.
Chicago ZitierstilTepper, Stewart J., Raghavendra Vasudeva, John H. Krege, Suchitrita S. Rathmann, Erin Doty, Bert B. Vargas, Delphine Magis, und Mika Komori. "Evaluation of 2‐Hour Post‐Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult‐to‐Treat Migraine Attacks." Headache 2020.
MLA ZitierstilTepper, Stewart J., et al. "Evaluation of 2‐Hour Post‐Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult‐to‐Treat Migraine Attacks." Headache 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.